Suhail Ayesh

Corporate Officer/Principal en The Hebrew University of Jerusalem .

Health Technology

Consumer Services

Perfil

Suhail Ayesh is Senior Researcher of BioCancell Therapeutics, Inc. He is Professor of Molecular Biochemistry and Gene Therapy at the Hebrew University of Jerusalem.
Mr. Ayesh is a Director of the Molecular Genetics Laboratory for Makassed Hospital.

Cargos activos de Suhail Ayesh

Empresas	Cargo	Inicio
The Hebrew University of Jerusalem	Corporate Officer/Principal	-
Al-Makassed Hospital	Corporate Officer/Principal	-

Todos los cargos activos de Suhail Ayesh

Antiguos cargos conocidos de Suhail Ayesh.

Empresas	Cargo	Fin
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Suhail Ayesh.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Suhail Ayesh.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Health Technology
Al-Makassed Hospital